68
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mechanisms of CFTR Functional Variants That Impair Regulated Bicarbonate Permeation and Increase Risk for Pancreatitis but Not for Cystic Fibrosis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          CFTR is a dynamically regulated anion channel. Intracellular WNK1-SPAK activation causes CFTR to change permeability and conductance characteristics from a chloride-preferring to bicarbonate-preferring channel through unknown mechanisms. Two severe CFTR mutations ( CFTR sev ) cause complete loss of CFTR function and result in cystic fibrosis (CF), a severe genetic disorder affecting sweat glands, nasal sinuses, lungs, pancreas, liver, intestines, and male reproductive system. We hypothesize that those CFTR mutations that disrupt the WNK1-SPAK activation mechanisms cause a selective, bicarbonate defect in channel function ( CFTR BD ) affecting organs that utilize CFTR for bicarbonate secretion (e.g. the pancreas, nasal sinus, vas deferens) but do not cause typical CF. To understand the structural and functional requirements of the CFTR bicarbonate-preferring channel, we (a) screened 984 well-phenotyped pancreatitis cases for candidate CFTR BD mutations from among 81 previously described CFTR variants; (b) conducted electrophysiology studies on clones of variants found in pancreatitis but not CF; (c) computationally constructed a new, complete structural model of CFTR for molecular dynamics simulation of wild-type and mutant variants; and (d) tested the newly defined CFTR BD variants for disease in non-pancreas organs utilizing CFTR for bicarbonate secretion. Nine variants ( CFTR R74Q, R75Q, R117H, R170H, L967S, L997F, D1152H, S1235R, and D1270N) not associated with typical CF were associated with pancreatitis (OR 1.5, p = 0.002). Clones expressed in HEK 293T cells had normal chloride but not bicarbonate permeability and conductance with WNK1-SPAK activation. Molecular dynamics simulations suggest physical restriction of the CFTR channel and altered dynamic channel regulation. Comparing pancreatitis patients and controls, CFTR BD increased risk for rhinosinusitis (OR 2.3, p<0.005) and male infertility (OR 395, p<<0.0001). WNK1-SPAK pathway-activated increases in CFTR bicarbonate permeability are altered by CFTR BD variants through multiple mechanisms. CFTR BD variants are associated with clinically significant disorders of the pancreas, sinuses, and male reproductive system.

          Author Summary

          Genetic disorders of ion channels can affect the body's ability to function properly in many ways. CFTR, an ion channel regulating movement of chloride and bicarbonate across cell membranes, is important for absorbing and secreting fluids. If the gene responsible for the CFTR channel is mutated severely, the result is cystic fibrosis, a hereditary disorder in which the patient develops thick mucus, especially in the lungs, as well as scarring (fibrosis) in the pancreas. Cystic fibrosis also affects the sweat glands, nasal sinuses, intestines, liver, and male reproductive system. Mutations to the CFTR gene that do not cause cystic fibrosis have been considered benign. However, we discovered 9 CFTR mutations that do not cause cystic fibrosis but do cause inflammation and scarring of the pancreas (chronic pancreatitis). These mutant CFTR channels secrete chloride, which is important in the sweat glands, lungs, and intestines, but not bicarbonate, which is important in the pancreas, sinuses, and male reproductive tract. We found patients with any of these 9 mutations had chronic pancreatitis, and often sinus infections, and male infertility, but not other symptoms of cystic fibrosis. Our computer models and data will help researchers develop better drugs and help physicians treating patients with chronic pancreatitis.

          Related collections

          Most cited references55

          • Record: found
          • Abstract: found
          • Article: not found

          Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.

          Secretory diarrhea is the leading cause of infant death in developing countries and a major cause of morbidity in adults. The cystic fibrosis transmembrane conductance regulator (CFTR) protein is required for fluid secretion in the intestine and airways and, when defective, causes the lethal genetic disease cystic fibrosis. We screened 50,000 chemically diverse compounds for inhibition of cAMP/flavone-stimulated Cl(-) transport in epithelial cells expressing CFTR. Six CFTR inhibitors of the 2-thioxo-4-thiazolidinone chemical class were identified. The most potent compound discovered by screening of structural analogs, CFTR(inh)-172, reversibly inhibited CFTR short-circuit current in less than 2 minutes in a voltage-independent manner with K(I) approximately 300 nM. CFTR(inh)-172 was nontoxic at high concentrations in cell culture and mouse models. At concentrations fully inhibiting CFTR, CFTR(inh)-172 did not prevent elevation of cellular cAMP or inhibit non-CFTR Cl(-) channels, multidrug resistance protein-1 (MDR-1), ATP-sensitive K(+) channels, or a series of other transporters. A single intraperitoneal injection of CFTR(inh)-172 (250 micro g/kg) in mice reduced by more than 90% cholera toxin-induced fluid secretion in the small intestine over 6 hours. Thiazolidinone CFTR inhibitors may be useful in developing large-animal models of cystic fibrosis and in reducing intestinal fluid loss in cholera and other secretory diarrheas.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function.

            Deletion of phenylalanine-508 (Phe-508) from the N-terminal nucleotide-binding domain (NBD1) of the cystic fibrosis transmembrane conductance regulator (CFTR), a member of the ATP-binding cassette (ABC) transporter family, disrupts both its folding and function and causes most cystic fibrosis. Most mutant nascent chains do not pass quality control in the ER, and those that do remain thermally unstable, only partially functional, and are rapidly endocytosed and degraded. Although the lack of the Phe-508 peptide backbone diminishes the NBD1 folding yield, the absence of the aromatic side chain is primarily responsible for defective CFTR assembly and channel gating. However, the site of interdomain contact by the side chain is unknown as is the high-resolution 3D structure of the complete protein. Here we present a 3D structure of CFTR, constructed by molecular modeling and supported biochemically, in which Phe-508 mediates a tertiary interaction between the surface of NBD1 and a cytoplasmic loop (CL4) in the C-terminal membrane-spanning domain (MSD2). This crucial cytoplasmic membrane interface, which is dynamically involved in regulation of channel gating, explains the known sensitivity of CFTR assembly to many disease-associated mutations in CL4 as well as NBD1 and provides a sharply focused target for small molecules to treat CF. In addition to identifying a key intramolecular site to be repaired therapeutically, our findings advance understanding of CFTR structure and function and provide a platform for focused biochemical studies of other features of this unique ABC ion channel.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway.

              It has recently been shown that the WNK [with-no-K(Lys)] kinases (WNK1, WNK2, WNK3 and WNK4) have vital roles in the control of salt homeostasis and blood pressure. This Commentary focuses on recent findings that have uncovered the backbone of a novel signal-transduction network that is controlled by WNK kinases. Under hyperosmotic or hypotonic low-Cl- conditions, WNK isoforms are activated, and subsequently phosphorylate and activate the related protein kinases SPAK and OSR1. SPAK and OSR1 phosphorylate and activate ion co-transporters that include NCC, NKCC1 and NKCC2, which are targets for the commonly used blood-pressure-lowering thiazide-diuretic and loop-diuretic drugs. The finding that mutations in WNK1, WNK4, NCC and NKCC2 cause inherited blood-pressure syndromes in humans highlights the importance of these enzymes. We argue that these new findings indicate that SPAK and OSR1 are promising drug targets for the treatment of hypertension, because inhibiting these enzymes would reduce NCC and NKCC2 activity and thereby suppress renal salt re-absorption. We also discuss unresolved and controversial questions in this field of research.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS Genet
                PLoS Genet
                plos
                plosgen
                PLoS Genetics
                Public Library of Science (San Francisco, USA )
                1553-7390
                1553-7404
                July 2014
                17 July 2014
                : 10
                : 7
                : e1004376
                Affiliations
                [1 ]Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
                [2 ]Department of Pharmacology and Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea
                [3 ]Department of Computational & Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
                [4 ]Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, United States of America
                [5 ]Department of Medicine, University of Michigan, Ann Arbor, Michigan, United States of America
                [6 ]Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America
                [7 ]Digestive Disease Center, Medical University of South Carolina, Charleston, South Carolina, United States of America
                [8 ]Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America
                [9 ]Department of Internal Medicine, St. Louis University School of Medicine, St Louis, Missouri, United States of America
                [10 ]Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, United States of America
                [11 ]Dartmouth-Hitchcock Medical Center, Hanover, New Hampshire, United States of America
                [12 ]North Mississippi Medical Center, Tupelo, Mississippi, United States of America
                [13 ]Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University Medical Center, Richmond, Virginia, United States of America
                [14 ]Department of Human Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
                [15 ]Department of Cell Biology and Molecular Physiology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
                Emory University School of Medicine, United States of Americs
                Author notes

                The authors have declared that no competing interests exist.

                Conceived and designed the experiments: IB MMB IJG JL MGL DCW. Performed the experiments: JL JJ IJG HWP AA. Analyzed the data: IB IJG MMB JL MGL DY DCW. Contributed reagents/materials/analysis tools: MDL REB AG MAA PAB DC CL JR JB SA GC TBG STA AS BS. Wrote the paper: IB IJG MLK JL MGL DCW. Ascertained and phenotyped patients: MDL REB AG MAA PAB DC CL JR JB SA TBG STA AS BS.

                [¤a]

                Current address: Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, California, United States of America

                [¤b]

                Current address: University of Chicago, Chicago, Illinois, United States of America

                [¤c]

                Current address: The Ohio State University, Columbus, Ohio, United States of America

                [¤d]

                Current address: Carteret Medical Group, Morehead City, North Carolina, United States of America

                [¤e]

                Current address: St Mary's Hospital, Richmond, Virginia, United States of America

                ¶ IB, MGL and DCW co-directed this project.

                ‡ Full membership of the North American Pancreatitis Study Group is provided in the Acknowledgments.

                Article
                PGENETICS-D-13-02984
                10.1371/journal.pgen.1004376
                4102440
                25033378
                f3a0549a-3116-408f-835f-3286b5af2b13
                Copyright @ 2014

                This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 26 October 2013
                : 10 March 2014
                Page count
                Pages: 15
                Funding
                The study was supported by R01DK061451 (DCW), R01GM086238 (IB), T32DK063922 (DCW), P30CA047904 (UPCI) and UL1 RR024153 and UL1TR000005 (GPCL, IB, IJG); the paper's contents are solely the responsibility of the authors and do not necessarily represent the official view of the National Institutes of Health. Funding was also provided by grant A111218-11-PG03 from the National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, Republic of Korea (MGL) and BK 21 Project for Medical Sciences, (JJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Research Article
                Biology and Life Sciences
                Anatomy
                Endocrine System
                Pancreas
                Biochemistry
                Proteins
                Developmental Biology
                Fibrosis
                Cystic Fibrosis
                Genetics
                Genetic Dominance
                Autosomal Recessive Traits
                Human Genetics
                Physiology
                Electrophysiology
                Medicine and Health Sciences
                Clinical Genetics
                Gastroenterology and Hepatology
                Pulmonology
                Respiratory Infections
                Upper Respiratory Tract Infections
                Urology
                Infertility

                Genetics
                Genetics

                Comments

                Comment on this article